Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1032 | 1058 | 1035 | 1082 | 1257 | 1507 |
Fund Return | 3.24% | 5.78% | 3.54% | 2.66% | 4.67% | 4.19% |
Place in category | 97 | 156 | 395 | 423 | 416 | 246 |
% in Category | 15 | 22 | 63 | 76 | 87 | 89 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SIHong Kong Equity C CHF Acc | 9.48B | 3.44 | -16.55 | 2.37 | ||
SIAsian Equity Yield C CHF Acc | 1.01B | 10.58 | -2.77 | 5.01 | ||
SISwiss Small Mid Cap Equity C Acc | 141.29M | 1.33 | -2.29 | 6.20 | ||
SISwiss Small Mid Cap Equity I Acc | 141.29M | 1.55 | -1.02 | 7.55 | ||
SISwiss Equity Opportunities I Acc | 32.46M | 3.41 | 3.68 | 5.31 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.52B | 3.85 | 3.74 | 6.24 | ||
Raiffeisen Futura Swiss Stock A | 2.19B | 2.12 | 2.41 | 6.12 | ||
UBS CH Equity Fund Swiss Income CHF | 1.8B | 2.43 | 3.56 | 5.81 | ||
UBS CH Equity Fund Swiss Income CHQ | 1.8B | 2.59 | 4.20 | 6.41 | ||
UBAM Swiss Equity AD CHF Inc | 1.78B | 7.99 | -0.55 | 5.90 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 9.15 | 92.77 | -0.42% | |
Nestle | CH0038863350 | 8.97 | 93.30 | -1.85% | |
Roche Holding Participation | CH0012032048 | 8.80 | 232.10 | +0.09% | |
Richemont | CH0210483332 | 5.90 | 142.25 | +1.17% | |
Zurich Insurance Group | CH0011075394 | 5.08 | 471.70 | +0.02% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review